Antibody?drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review). Yang C, Wang L, Gong C, Lv D, et al. Oncol Rep 2025;53:21.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang C, Wang L, Gong C, Lv D, et al. Antibody?drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review). Oncol Rep 2025;53:21.
PMID: 39670293